We are live on
!
Find out more
WCM
Wallace Capital Management Portfolio holdings
AUM
$912M
1-Year Est. Return
21.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+21.45%
3 Year Est. Return
+62.28%
5 Year Est. Return
+56.95%
10 Year Est. Return
+224.78%
AUM
$568M
AUM Growth
+$45.6M
(+8.7%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
68.58%
Holding
57
New
3
Increased
29
Reduced
13
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Graham Holdings Company
GHC
|
+$2.44M |
| 2 |
ASCMA
Ascent Capital Group, Inc. Series A
ASCMA
|
+$1.82M |
| 3 |
White Mountains Insurance
WTM
|
+$1.22M |
| 4 |
FFH
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
|
+$1.18M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$221K |
| 2 |
JPMorgan Chase
JPM
|
+$206K |
| 3 |
Iron Mountain
IRM
|
+$144K |
| 4 |
Colgate-Palmolive
CL
|
+$87.6K |
| 5 |
Clorox
CLX
|
+$84K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.66% |
| 2 | Industrials | 20.32% |
| 3 | Consumer Discretionary | 15.2% |
| 4 | Materials | 10.75% |
| 5 | Consumer Staples | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pfizer
PFE
$158B
| $276K | 0.05% |
8,371
| – | – |
|
|
52
Iron Mountain
IRM
$33.9B
| $269K | 0.05% |
7,382
-3,734
| -34% | -$144K |
|
53
McDonald's
MCD
$176B
| $214K | 0.04% |
+2,199
| New | +$209K |
|
|
CB
54
DELISTED
CHUBB CORPORATION
CB
| $211K | 0.04% |
2,087
| – | – |
|
|
55
AbbVie
ABBV
$467B
| – | – |
-3,381
| Closed | -$221K |
|
|
56
JPMorgan Chase
JPM
$929B
| – | – |
-3,294
| Closed | -$206K |
|
Similar funds
CG
JSL
NCM
PIP
PWA
IPAM
ACA
MA
Wallace Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Wallace Capital Management held 57 positions worth $568M, up 8.7% from $522M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Wallace Capital Management's Q1 2015 filing shows 3 new, 29 increased, 13 reduced and 3 closed positions. Its largest new stake was Eli Lilly: 6,879 shares worth $500K. The largest sale was AbbVie, an estimated $221K.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Wallace Capital Management's largest Q1 2015 buy was Eli Lilly: 6,879 shares worth $500K.
- Wallace Capital Management added most to Graham Holdings Company in Q1 2015, an estimated $2.44M increase.
- Wallace Capital Management's biggest Q1 2015 reduction was Iron Mountain, cutting an estimated $144K.
- Wallace Capital Management fully exited AbbVie in Q1 2015, selling an estimated $221K.
- Wallace Capital Management's ten largest holdings make up 69% of its $568M portfolio in Q1 2015.
- Wallace Capital Management opened 3 new positions and closed 3 in Q1 2015.
- Wallace Capital Management's portfolio value rose 8.7% quarter-over-quarter to $568M.
Based on Wallace Capital Management's 13F filing for Q1 2015, filed 14 May 2015.